Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Feb 15;18(4):1014–1024. doi: 10.1093/emboj/18.4.1014

The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

S K Petersen-Mahrt 1, C Estmer 1, C Ohrmalm 1, D A Matthews 1, W C Russell 1, G Akusjärvi 1
PMCID: PMC1171193  PMID: 10022843

Abstract

The cellular protein p32 was isolated originally as a protein tightly associated with the essential splicing factor ASF/SF2 during its purification from HeLa cells. ASF/SF2 is a member of the SR family of splicing factors, which stimulate constitutive splicing and regulate alternative RNA splicing in a positive or negative fashion, depending on where on the pre-mRNA they bind. Here we present evidence that p32 interacts with ASF/SF2 and SRp30c, another member of the SR protein family. We further show that p32 inhibits ASF/SF2 function as both a splicing enhancer and splicing repressor protein by preventing stable ASF/SF2 interaction with RNA, but p32 does not block SRp30c function. ASF/SF2 is highly phosphorylated in vivo, a modification required for stable RNA binding and protein-protein interaction during spliceosome formation, and this phosphorylation, either through HeLa nuclear extracts or through specific SR protein kinases, is inhibited by p32. Our results suggest that p32 functions as an ASF/SF2 inhibitory factor, regulating ASF/SF2 RNA binding and phosphorylation. These findings place p32 into a new group of proteins that control RNA splicing by sequestering an essential RNA splicing factor into an inhibitory complex.

Full Text

The Full Text of this article is available as a PDF (465.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin A. S., Jr The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683. doi: 10.1146/annurev.immunol.14.1.649. [DOI] [PubMed] [Google Scholar]
  2. Bruni R., Roizman B. Open reading frame P--a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10423–10427. doi: 10.1073/pnas.93.19.10423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  4. Cao W., Jamison S. F., Garcia-Blanco M. A. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA. 1997 Dec;3(12):1456–1467. [PMC free article] [PubMed] [Google Scholar]
  5. Chabot B., Blanchette M., Lapierre I., La Branche H. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol. 1997 Apr;17(4):1776–1786. doi: 10.1128/mcb.17.4.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen M. R., Yang J. F., Wu C. W., Middeldorp J. M., Chen J. Y. Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin. J Biomed Sci. 1998;5(3):173–179. doi: 10.1007/BF02253466. [DOI] [PubMed] [Google Scholar]
  7. Colwill K., Pawson T., Andrews B., Prasad J., Manley J. L., Bell J. C., Duncan P. I. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J. 1996 Jan 15;15(2):265–275. [PMC free article] [PubMed] [Google Scholar]
  8. Cáceres J. F., Screaton G. R., Krainer A. R. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 1998 Jan 1;12(1):55–66. doi: 10.1101/gad.12.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dedio J., Jahnen-Dechent W., Bachmann M., Müller-Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998 Apr 1;160(7):3534–3542. [PubMed] [Google Scholar]
  10. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Duncan P. I., Stojdl D. F., Marius R. M., Bell J. C. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol Cell Biol. 1997 Oct;17(10):5996–6001. doi: 10.1128/mcb.17.10.5996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eggleton P., Ghebrehiwet B., Sastry K. N., Coburn J. P., Zaner K. S., Reid K. B., Tauber A. I. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest. 1995 Apr;95(4):1569–1578. doi: 10.1172/JCI117830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fu X. D., Mayeda A., Maniatis T., Krainer A. R. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11224–11228. doi: 10.1073/pnas.89.23.11224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fu X. D. The superfamily of arginine/serine-rich splicing factors. RNA. 1995 Sep;1(7):663–680. [PMC free article] [PubMed] [Google Scholar]
  15. Ge H., Manley J. L. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell. 1990 Jul 13;62(1):25–34. doi: 10.1016/0092-8674(90)90236-8. [DOI] [PubMed] [Google Scholar]
  16. Ge H., Zuo P., Manley J. L. Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators. Cell. 1991 Jul 26;66(2):373–382. doi: 10.1016/0092-8674(91)90626-a. [DOI] [PubMed] [Google Scholar]
  17. Ghebrehiwet B., Lu P. D., Zhang W., Keilbaugh S. A., Leigh L. E., Eggleton P., Reid K. B., Peerschke E. I. Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex. J Immunol. 1997 Aug 1;159(3):1429–1436. [PubMed] [Google Scholar]
  18. Gilmartin G. M., Fleming E. S., Oetjen J. Activation of HIV-1 pre-mRNA 3' processing in vitro requires both an upstream element and TAR. EMBO J. 1992 Dec;11(12):4419–4428. doi: 10.1002/j.1460-2075.1992.tb05542.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gui J. F., Tronchère H., Chandler S. D., Fu X. D. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10824–10828. doi: 10.1073/pnas.91.23.10824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Guo N., Weremowicz S., Lynch N., Lim B. L., Schwaeble W., Peerschke E. I., Morton C. C., Reid K. B., Ghebrehiwet B., Sastry K. N. Assignment of C1QBP encoding the C1q globular domain binding protein (gC1q-R) to human chromosome 17 band p13.3 by in situ hybridization. Cytogenet Cell Genet. 1997;77(3-4):283–284. doi: 10.1159/000134598. [DOI] [PubMed] [Google Scholar]
  21. Hanamura A., Cáceres J. F., Mayeda A., Franza B. R., Jr, Krainer A. R. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA. 1998 Apr;4(4):430–444. [PMC free article] [PubMed] [Google Scholar]
  22. Harper J. E., Manley J. L. A novel protein factor is required for use of distal alternative 5' splice sites in vitro. Mol Cell Biol. 1991 Dec;11(12):5945–5953. doi: 10.1128/mcb.11.12.5945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Imperiale M. J., Akusjnärvi G., Leppard K. N. Post-transcriptional control of adenovirus gene expression. Curr Top Microbiol Immunol. 1995;199(Pt 2):139–171. doi: 10.1007/978-3-642-79499-5_6. [DOI] [PubMed] [Google Scholar]
  24. Jiang Z. H., Zhang W. J., Rao Y., Wu J. Y. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9155–9160. doi: 10.1073/pnas.95.16.9155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kanopka A., Mühlemann O., Akusjärvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature. 1996 Jun 6;381(6582):535–538. doi: 10.1038/381535a0. [DOI] [PubMed] [Google Scholar]
  26. Kanopka A., Mühlemann O., Petersen-Mahrt S., Estmer C., Ohrmalm C., Akusjärvi G. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature. 1998 May 14;393(6681):185–187. doi: 10.1038/30277. [DOI] [PubMed] [Google Scholar]
  27. Krainer A. R., Conway G. C., Kozak D. The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites. Cell. 1990 Jul 13;62(1):35–42. doi: 10.1016/0092-8674(90)90237-9. [DOI] [PubMed] [Google Scholar]
  28. Krainer A. R., Mayeda A., Kozak D., Binns G. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell. 1991 Jul 26;66(2):383–394. doi: 10.1016/0092-8674(91)90627-b. [DOI] [PubMed] [Google Scholar]
  29. Kreivi J. P., Akusjärvi G. Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation. Nucleic Acids Res. 1994 Feb 11;22(3):332–337. doi: 10.1093/nar/22.3.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kreivi J. P., Zerivitz K., Zefrivitz K., Akusjärvi G. A U1 snRNA binding site improves the efficiency of in vitro pre-mRNA splicing. Nucleic Acids Res. 1991 Dec 25;19(24):6956–6956. doi: 10.1093/nar/19.24.6956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Luo Y., Yu H., Peterlin B. M. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J Virol. 1994 Jun;68(6):3850–3856. doi: 10.1128/jvi.68.6.3850-3856.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Manley J. L., Tacke R. SR proteins and splicing control. Genes Dev. 1996 Jul 1;10(13):1569–1579. doi: 10.1101/gad.10.13.1569. [DOI] [PubMed] [Google Scholar]
  33. Matthews D. A., Russell W. C. Adenovirus core protein V interacts with p32--a protein which is associated with both the mitochondria and the nucleus. J Gen Virol. 1998 Jul;79(Pt 7):1677–1685. doi: 10.1099/0022-1317-79-7-1677. [DOI] [PubMed] [Google Scholar]
  34. Mayeda A., Helfman D. M., Krainer A. R. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol Cell Biol. 1993 May;13(5):2993–3001. doi: 10.1128/mcb.13.5.2993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mayeda A., Krainer A. R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell. 1992 Jan 24;68(2):365–375. doi: 10.1016/0092-8674(92)90477-t. [DOI] [PubMed] [Google Scholar]
  36. Mermoud J. E., Cohen P. T., Lamond A. I. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J. 1994 Dec 1;13(23):5679–5688. doi: 10.1002/j.1460-2075.1994.tb06906.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Misteli T., Spector D. L. Protein phosphorylation and the nuclear organization of pre-mRNA splicing. Trends Cell Biol. 1997 Apr;7(4):135–138. doi: 10.1016/S0962-8924(96)20043-1. [DOI] [PubMed] [Google Scholar]
  38. Muta T., Kang D., Kitajima S., Fujiwara T., Hamasaki N. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997 Sep 26;272(39):24363–24370. doi: 10.1074/jbc.272.39.24363. [DOI] [PubMed] [Google Scholar]
  39. Nevins J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 1992 Oct 16;258(5081):424–429. doi: 10.1126/science.1411535. [DOI] [PubMed] [Google Scholar]
  40. Peterson K. L., Zhang W., Lu P. D., Keilbaugh S. A., Peerschke E. I., Ghebrehiwet B. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization. Clin Immunol Immunopathol. 1997 Jul;84(1):17–26. doi: 10.1006/clin.1997.4374. [DOI] [PubMed] [Google Scholar]
  41. Reed R., Maniatis T. A role for exon sequences and splice-site proximity in splice-site selection. Cell. 1986 Aug 29;46(5):681–690. doi: 10.1016/0092-8674(86)90343-0. [DOI] [PubMed] [Google Scholar]
  42. Screaton G. R., Cáceres J. F., Mayeda A., Bell M. V., Plebanski M., Jackson D. G., Bell J. I., Krainer A. R. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 1995 Sep 1;14(17):4336–4349. doi: 10.1002/j.1460-2075.1995.tb00108.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Simos G., Georgatos S. D. The lamin B receptor-associated protein p34 shares sequence homology and antigenic determinants with the splicing factor 2-associated protein p32. FEBS Lett. 1994 Jun 13;346(2-3):225–228. doi: 10.1016/0014-5793(94)00479-x. [DOI] [PubMed] [Google Scholar]
  44. Sun Q., Mayeda A., Hampson R. K., Krainer A. R., Rottman F. M. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 1993 Dec;7(12B):2598–2608. doi: 10.1101/gad.7.12b.2598. [DOI] [PubMed] [Google Scholar]
  45. Tacke R., Chen Y., Manley J. L. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1148–1153. doi: 10.1073/pnas.94.4.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tange T. O., Jensen T. H., Kjems J. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. J Biol Chem. 1996 Apr 26;271(17):10066–10072. doi: 10.1074/jbc.271.17.10066. [DOI] [PubMed] [Google Scholar]
  47. Wang J., Takagaki Y., Manley J. L. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 1996 Oct 15;10(20):2588–2599. doi: 10.1101/gad.10.20.2588. [DOI] [PubMed] [Google Scholar]
  48. Wang Y., Finan J. E., Middeldorp J. M., Hayward S. D. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology. 1997 Sep 15;236(1):18–29. doi: 10.1006/viro.1997.8739. [DOI] [PubMed] [Google Scholar]
  49. Whiteside S. T., Israël A. I kappa B proteins: structure, function and regulation. Semin Cancer Biol. 1997 Apr;8(2):75–82. doi: 10.1006/scbi.1997.0058. [DOI] [PubMed] [Google Scholar]
  50. Xiao S. H., Manley J. L. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 1997 Feb 1;11(3):334–344. doi: 10.1101/gad.11.3.334. [DOI] [PubMed] [Google Scholar]
  51. Yang X., Bani M. R., Lu S. J., Rowan S., Ben-David Y., Chabot B. The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6924–6928. doi: 10.1073/pnas.91.15.6924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yu L., Loewenstein P. M., Zhang Z., Green M. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J Virol. 1995 May;69(5):3017–3023. doi: 10.1128/jvi.69.5.3017-3023.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zuo P., Maniatis T. The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 1996 Jun 1;10(11):1356–1368. doi: 10.1101/gad.10.11.1356. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES